| Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ... Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015 | 339 | 2015 |
| Marked, homogeneous, and early [18F] fluorodeoxyglucose–positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma GA McArthur, I Puzanov, R Amaravadi, A Ribas, P Chapman, KB Kim, ... Journal of Clinical Oncology 30 (14), 1628, 2012 | 180 | 2012 |
| Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging JA Hayman, JW Callahan, A Herschtal, S Everitt, DS Binns, RJ Hicks, ... International Journal of Radiation Oncology* Biology* Physics 79 (3), 847-852, 2011 | 150 | 2011 |
| Efficacy of peptide receptor radionuclide therapy for functional metastatic paraganglioma and pheochromocytoma G Kong, S Grozinsky-Glasberg, MS Hofman, J Callahan, A Meirovitz, ... The Journal of Clinical Endocrinology & Metabolism 102 (9), 3278-3287, 2017 | 146 | 2017 |
| Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN)-a single-institution retrospective … SP Thang, MS Lung, G Kong, MS Hofman, J Callahan, M Michael, ... European journal of nuclear medicine and molecular imaging 45, 262-277, 2018 | 133 | 2018 |
| Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA L Tan, S Sandhu, RJ Lee, J Li, J Callahan, S Ftouni, N Dhomen, ... Annals of Oncology 30 (5), 804-814, 2019 | 129 | 2019 |
| Validating and improving CT ventilation imaging by correlating with ventilation 4D‐PET/CT using 68Ga‐labeled nanoparticles J Kipritidis, S Siva, MS Hofman, J Callahan, RJ Hicks, PJ Keall Medical physics 41 (1), 011910, 2014 | 119 | 2014 |
| Circulating tumor DNA analysis and functional imaging provide complementary approaches for comprehensive disease monitoring in metastatic melanoma SQ Wong, JM Raleigh, J Callahan, IA Vergara, S Ftouni, A Hatzimihalis, ... Precision Oncology 1, 1-14, 2017 | 108 | 2017 |
| Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients E Quak, PY Le Roux, MS Hofman, P Robin, D Bourhis, J Callahan, ... European journal of nuclear medicine and molecular imaging 42, 2072-2082, 2015 | 107 | 2015 |
| High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer S Siva, R Thomas, J Callahan, N Hardcastle, D Pham, T Kron, RJ Hicks, ... Radiotherapy and Oncology 115 (2), 157-162, 2015 | 106 | 2015 |
| Utility of 68Ga prostate specific membrane antigen – positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma S Siva, J Callahan, D Pryor, J Martin, N Lawrentschuk, MS Hofman Journal of medical imaging and radiation oncology 61 (3), 372-378, 2017 | 101 | 2017 |
| 64Cu-SARTATE PET imaging of patients with neuroendocrine tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor … RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman, DA Pattison, ... Journal of Nuclear Medicine 60 (6), 777-785, 2019 | 98 | 2019 |
| Abscopal effects after conventional and stereotactic lung irradiation of non–small-cell lung cancer S Siva, J Callahan, MP MacManus, O Martin, RJ Hicks, DL Ball Journal of Thoracic Oncology 8 (8), e71-e72, 2013 | 95 | 2013 |
| 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience S Siva, K Byrne, M Seel, M Bressel, D Jacobs, J Callahan, J Laing, ... Journal of Nuclear Medicine 54 (8), 1223-1229, 2013 | 91 | 2013 |
| Supranutritional sodium selenate supplementation delivers selenium to the central nervous system: results from a randomized controlled pilot trial in Alzheimer’s disease BR Cardoso, BR Roberts, CB Malpas, L Vivash, S Genc, MM Saling, ... Neurotherapeutics 16, 192-202, 2019 | 87 | 2019 |
| Differential 18F-FDG and 18F-FLT uptake on serial PET/CT imaging before and during definitive chemoradiation for non–small cell lung cancer SJ Everitt, DL Ball, RJ Hicks, J Callahan, N Plumridge, M Collins, ... Journal of Nuclear Medicine 55 (7), 1069-1074, 2014 | 85 | 2014 |
| High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose‐positron emission tomography/computed tomography scans in radical … S Everitt, A Herschtal, J Callahan, N Plumridge, D Ball, T Kron, ... Cancer 116 (21), 5030-5037, 2010 | 85 | 2010 |
| A phase IIa randomized control trial of VEL015 (Sodium Selenate) in mild-moderate Alzheimer’s disease CB Malpas, L Vivash, S Genc, MM Saling, P Desmond, C Steward, ... Journal of Alzheimer's Disease 54 (1), 223-232, 2016 | 82 | 2016 |
| Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour EWF Lau, KJ Drummond, RE Ware, E Drummond, A Hogg, G Ryan, ... Journal of Clinical Neuroscience 17 (1), 43-49, 2010 | 81 | 2010 |
| The VAMPIRE challenge: a multi‐institutional validation study of CT ventilation imaging J Kipritidis, BA Tahir, G Cazoulat, MS Hofman, S Siva, J Callahan, ... Medical physics 46 (3), 1198-1217, 2019 | 73 | 2019 |
